Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
- Resource Type
- Article
- Authors
- Jurczak, Wojciech; Elmusharaf, Nagah; Fox, Christopher P.; Townsend, William; Paulovich, Amanda G.; Whiteaker, Jeffrey R.; Krantz, Fanny; Wun, Chuan-Chuan; Parr, Graeme; Sharma, Shringi; Munugalavadla, Veerendra; Manwani, Richa; Dean, Emma; Munir, Talha
- Source
- Therapeutic Advances in Hematology; Jan-Dec2023, Vol. 14, p1-14, 14p
- Subject
- Language
- ISSN
- 20406207